Cardinal Health, Inc. $CAH Shares Sold by Transcend Capital Advisors LLC

Transcend Capital Advisors LLC cut its holdings in Cardinal Health, Inc. (NYSE:CAH) by 4.0% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 2,637 shares of the company’s stock after selling 109 shares during the period. Transcend Capital Advisors LLC’s holdings in Cardinal Health were worth $443,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Principal Financial Group Inc. lifted its position in Cardinal Health by 5.3% in the first quarter. Principal Financial Group Inc. now owns 315,817 shares of the company’s stock valued at $43,510,000 after buying an additional 15,956 shares during the last quarter. Golden State Wealth Management LLC raised its stake in shares of Cardinal Health by 569.5% in the 1st quarter. Golden State Wealth Management LLC now owns 395 shares of the company’s stock valued at $54,000 after acquiring an additional 336 shares during the period. North Capital Inc. acquired a new position in shares of Cardinal Health in the 1st quarter worth approximately $83,000. KLP Kapitalforvaltning AS boosted its position in shares of Cardinal Health by 4.0% during the 2nd quarter. KLP Kapitalforvaltning AS now owns 114,198 shares of the company’s stock worth $19,185,000 after purchasing an additional 4,400 shares during the period. Finally, Czech National Bank increased its holdings in Cardinal Health by 5.1% in the 2nd quarter. Czech National Bank now owns 58,341 shares of the company’s stock valued at $9,801,000 after purchasing an additional 2,857 shares during the last quarter. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Stock Performance

Shares of Cardinal Health stock opened at $164.59 on Thursday. The business has a 50-day simple moving average of $153.56 and a 200-day simple moving average of $153.73. Cardinal Health, Inc. has a one year low of $106.98 and a one year high of $168.44. The company has a market cap of $39.10 billion, a PE ratio of 25.52, a P/E/G ratio of 1.38 and a beta of 0.71.

Cardinal Health (NYSE:CAH) last issued its earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, beating the consensus estimate of $2.03 by $0.05. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The firm had revenue of $60.16 billion for the quarter, compared to analysts’ expectations of $60.91 billion. During the same quarter last year, the company earned $1.84 earnings per share. The firm’s revenue was up .5% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. On average, sell-side analysts predict that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st were paid a dividend of $0.5107 per share. The ex-dividend date was Wednesday, October 1st. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.2%. Cardinal Health’s payout ratio is presently 31.63%.

Insider Transactions at Cardinal Health

In other news, insider Jessica L. Mayer sold 38,078 shares of the company’s stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $5,666,767.96. Following the completion of the transaction, the insider directly owned 48,457 shares of the company’s stock, valued at approximately $7,211,370.74. This represents a 44.00% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Ola M. Snow sold 28,151 shares of the firm’s stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.94, for a total value of $4,192,809.94. Following the sale, the insider directly owned 15,431 shares in the company, valued at $2,298,293.14. This trade represents a 64.59% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 271,676 shares of company stock valued at $40,489,525 over the last ninety days. Company insiders own 0.12% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on CAH shares. Wall Street Zen cut Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 2nd. Evercore ISI lowered their target price on Cardinal Health from $200.00 to $190.00 and set an “outperform” rating for the company in a report on Wednesday, August 13th. UBS Group reaffirmed a “buy” rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Wells Fargo & Company reissued an “overweight” rating and set a $185.00 price target (up previously from $183.00) on shares of Cardinal Health in a research report on Wednesday, August 13th. Finally, Weiss Ratings restated a “buy (b)” rating on shares of Cardinal Health in a report on Wednesday, October 8th. Twelve research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $166.00.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.